Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
26
datasets available to search
ShareScore release 0.9.0
Dataset results
26 results for “nephroprotective”
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
ClinicalTrials.gov study NCT00256750. IPD Sharing: Not stated. Countries: 21. Publications: 3.
Measurement of renal failure biomarkers for the: Nephroprotective Effect of Vitamin D Against Levofloxacin-Induced Renal Injury: an observational study
<p>Measurement of renal failure biomarkers for the: Nephroprotective Effect of Vitamin D Against Levofloxacin-Induced Renal Injury: an observational study</p>
The ARRIVE Essential 10: author checklist – Nephroprotective Effect of Vitamin D Against Levofloxacin-Induced Renal Injury: an observational study.
<p>The ARRIVE Essential 10: author checklist – Nephroprotective Effect of Vitamin D Against Levofloxacin-Induced Renal Injury: an observational study.</p>
Post-preeclampsia Renal Project: Study of Nephroprotection in Women Having Suffered Preeclampsia
ClinicalTrials.gov study NCT01095939. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
ClinicalTrials.gov study NCT01218178. IPD Sharing: Not stated. Countries: 1. Publications: 17.
The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
ClinicalTrials.gov study NCT06215976. IPD Sharing: YES. Countries: 1. Publications: 1.
Remote Ischemic Preconditioning as a New Method of Nephroprotection
ClinicalTrials.gov study NCT03205410. IPD Sharing: YES. Countries: 1. Publications: 1.
Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)
ClinicalTrials.gov study NCT00157586. IPD Sharing: Not stated. Countries: 2. Publications: 3.
UCP1 mediates nephroprotection of ANXA1 in DN
Open the record for dataset details and reuse information.
Figure 6 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 6 Kidney sections (A) control. B, C. STZ-treated diabetic-rat showing atrophy of glomerular tuft (white arrow in B arrow), increase in the Bowman's space area and degeneration of renal tubules (Black arrow in C) associated with severe hemorrhage and congestion of renal blood vessels; D. Extract-treated rats. Renal tubules (Black arrow), Bowman's capsule (white arrow); E, F. Metformin-treated rats. H & E stain.
Figure 5 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 5 Liver tissue sections of (A) control; B. STZ-treated diabetic-rat; C. Extract-treated rats; D. Metformin-treated rats. White arrows: Central vein. Black arrows: Sinosoids. H& E stain.
Figure 3 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 3 Final Mean values of Urea serum levels at the end of the study. Abbreviations: C = non-diabetic control group, SDM = STZ-induced diabetic rats, SDMET = STZ-induced diabetic rat + metformin (50 mg/kg/day), Q2 = Low dose extract (200 mg/kg/day), SDMQ2 = STZ-induced diabetic rats + Low dose extract (200 mg/kg/day), Q3 =: High dose extract (300 mg/kg/day), SDMQ3 = STZ-induced diabetic rats + High dose extract (300 mg/kg/day). NOTE: Results are represented as Mean±SD (n=6 for each group). * p < 0.05, ** p < 0.01, and *** p < 0.001 when compared with the SDM; • p < 0.05, •• p < 0.01, and •••p < 0.001 when compared with the SDMT (Dunnett's Multiple Comparisons Test).
Figure 4 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 4 Final Mean values of Urea serum levels at the end of the study. Abbreviations: C = non-diabetic control group, SDM = STZ induced diabetic rats, SDMET = STZ-induced diabetic rat + metformin (50 mg/kg/day), Q2 = Low dose extract (200 mg/kg/day), SDMQ2 = STZ-induced diabetic rats + Low dose extract (200 mg/kg/day), Q3 =: High dose extract (300 mg/kg/day), SDMQ3 = STZ-induced diabetic rats+ High dose extract (300 mg/kg/day). NOTE: Results are represented as Mean±SD (n=6 for each group). * p < 0.05, ** p < 0.01, and *** p < 0.001 when compared with the SDM; • p < 0.05, •• p < 0.01, and •••p < 0.001 when compared with the SDMT (Dunnett's Multiple Comparisons Test).
Optimalization of Nephroprotection Using Atorvastatin (Sortis)
ClinicalTrials.gov study NCT00572312. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
ClinicalTrials.gov study NCT00528385. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Optimalization of Nephroprotection Using N-Acetylcysteine
ClinicalTrials.gov study NCT00572663. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Figure 2 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 2 Chromatogram of E. ramosissimum ethanol extract.
Figure 1 from: Abdullah RK, Issa RA, Abu-Samak M, Mohammad BA, Abbas MA, Awwad SH (2024) Nephroprotective effects of Equisetum ramosissimum L. extract in streptozotocin-induced diabetic rats. Pharmacia 71: 1-11. https://doi.org/10.3897/pharmacia.71.e113659
Figure 1 Chromatogram of E. ramosissimum methanol extract.
Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population
ClinicalTrials.gov study NCT07038213. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Nephroprotective Effect of Pentoxifylline Against Cisplatin in Patients With Head and Neck Cancer
ClinicalTrials.gov study NCT05640817. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.